U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07658443) titled 'Evaluating DFPP for Microplastic Reduction' on June 14.
Brief Summary: This prospective, non-interventional, within-subject paired biomarker study will evaluate whether circulating microplastic and nanoplastic-associated particle concentrations in peripheral blood change after clinically prescribed double-filtration plasmapheresis (DFPP). Twenty adult volunteers already undergoing DFPP independent of research participation will provide paired pre- and post-treatment blood samples. The primary endpoint is within-participant change in microplastic and nanoplastic-associated particle concentration measured by nano-flow cytometry with N...